Trade Bristol Myers ^BMY

Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years | Morningstar

Bristol Myers Squibb Company Declares Quarterly Dividend of $0.63 (NYSE:BMY)

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

Bristol Myers Squibb Declares Quarterly Dividend As Part Of Ongoing Shareholder Return Strategy

Bristol Myers Squibb identifies new muscarinic receptor agonists | BioWorld

Dr Reddy's forays into Indian biosimilar immuno-oncology market

Dr Reddy's Launches Nivorz: A Game-Changer in India's Cancer Treatment Market, ETPharma

Dr Reddy's launches Opdivo biosimilar Nivorz in India, enters immuno-oncology segment

Zacks Research Has Positive Outlook for BMY Q3 Earnings - Zolmax

The Bull Case For Bristol Myers Squibb (BMY) Could Change Following Arlo-cel's Positive Phase 2 Myeloma Data

Lockheed's Pension Risk Transfer Appeal Tests Retiree Rights

Zacks Research Issues Positive Estimate for BMY Earnings - Daily Political

RBC Capital Sticks to Their Buy Rating for AstraZeneca (AZN)

RBC Capital Sticks to Their Buy Rating for Roche Holding AG (RHHVF)

RBC Capital Sticks to Their Buy Rating for AbbVie (ABBV)

GlaxoSmithKline (GSK) Gets a Hold from RBC Capital

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)

RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?

Bristol Myers Squibb Company $BMY Shares Bought by The Manufacturers Life Insurance Company

New FDA Drug Approvals - August 2026

Bristol Myers' Cancer Therapy Win Strengthens its Oncology Pipeline

RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors

Investors Purchase Large Volume of Put Options on Bristol Myers Squibb (NYSE:BMY) - Zolmax

BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock?

Investors Purchase Large Volume of Put Options on Bristol Myers Squibb (NYSE:BMY) - Daily Political

Cloud vs On-Prem AI in 2026: Is Renting GPUs Cheaper Than Buying AI Servers?

Graft Versus Host Disease Market to Reach Significant Growth by 2036, Driven by Rising Transplant Procedures, Targeted Therapies, and Emerging Cell-based Treatment Approaches | DelveInsight | ABNewswire

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception | ABNewswire

A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial

Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire

Multiple Myeloma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb | ABNewswire

Interstitial Lung Disease Market Size is Projected to Grow from USD 6 Billion at a CAGR of 8.7% By 2036| DelveInsight | ABNewswire

Interstitial Lung Disease Clinical Trial Drug Development Pipeline Expands with Contributions from 120+ Key Companies | DelveInsight | ABNewswire

REBLOZYL Sales Forecast and Market Size Analysis 2020-2034 | New Indications Broaden REBLOZYL Market Potential | Valuespectrum.com

Could Bristol-Myers Squibb (BMY) Outperform Novartis (NVS) as CAR-T Safety Concerns Shake the Sector?

Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?

BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM

Bristol Myers Squibb Reports Positive Phase 2 Results For Arlo-cel In Multiple Myeloma

Bristol Myers' Breakthrough Cell Therapy for Blood Cancer Shows Promising Results in Mid-Stage Trial, ETPharma

Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - Daily Political

RBC Capital downgrades Novartis AG (NOVN) to a Hold

RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

Carmignac Gestion Buys New Shares in Bristol Myers Squibb Company $BMY - Zolmax

RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)

Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score

Social Security's 2027 COLA Raise Is the Biggest in 3 Years - But These 5 Dividend Stocks Pay You More

Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ... | Morningstar

Bristol Myers Squibb Company $BMY Shares Acquired by Amundi

Bristol Myers Squibb Company $BMY Shares Sold by HighTower Advisors LLC - Daily Political

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight | Valuespectrum.com

Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now

Bristol Myers Squibb Company (NYSE:BMY) Receives Average Recommendation of "Moderate Buy" from Analysts - Markets Daily

VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 1,722,230 Bristol Myers Squibb Company $BMY - Stock Observer

Paralel Advisors LLC Buys New Position in Bristol Myers Squibb Company $BMY - Daily Political

Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility

Wall Street Money Is Leaving Just As Atrium's (RNA) Pipeline Turns Real

Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc.

Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC

Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC

Bristol Myers Squibb Company $BMY Shares Acquired by Three Seasons Wealth LLC - Stock Observer

7,970 Shares in Bristol Myers Squibb Company $BMY Purchased by OceanIQ Capital LLC - Stock Observer

Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today

Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc.

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1

Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report?

Eikon Therapeutics Appoints Ching-Pin Chang As Executive VP & Chief Scientific Officer

What Does Bristol Myers Squibb (BMY) Trial Pause Mean For Its Pipeline?

Rural Pharmacies Identify Thousands of Patients at Risk of Stroke, Heart Disease, Pilot Program Finds

2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

Bristol Myers Squibb (BMY) Gains On Camzyos Data, Is The Upside Already Priced In?

Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest

Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis

3 Reasons to Sell BMY and 1 Stock to Buy Instead

Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Rating of "Moderate Buy" from Analysts

Quantitative Investment Management LLC Makes New Investment in Bristol Myers Squibb Company $BMY

Wellington Management Group LLP Has $225.53 Million Holdings in Bristol Myers Squibb Company $BMY

Benjamin Edwards Inc. Acquires 18,656 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Rating of "Moderate Buy" from Brokerages - Stock Observer

Benjamin Edwards Inc. Buys 18,656 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Wellington Management Group LLP Sells 1,592,910 Shares of Bristol Myers Squibb Company $BMY - Daily Political

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Week ahead: Fed to hike 100bps into a recession?

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk